Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
XBB.1.5 (46.4%)⬇️
XBB.1.9.1 (10.1%)⬆️
XBB.1.16 (4.9%)⬆️
EG.1 (3.7%)⬆️
CH.1.1 (2.3%)⬇️
XBB.1.9.2 (2.3%)
--
XBB.2.3 (1.3%)⬆️
Tracker: public.tableau.com/app/profile/ra…
Updated 04/15/23
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 03/26/2023 (15,505 sequences)
#USA, #Austria, #UnitedKingdom & #Canada have submitted a lion's share of sequences with sample collection dates on or after 03/26/2023 ...followed by #Germany, #France, #India, #Italy, #Australia, #Sweden, #Denmark, #Singapore, #SouthKorea, #Spain, #Netherlands
In Silico Immune escape and ACE2 receptor binding scores (relative to BA.2)*
Data is intended to prioritize select lineages to generate rapid laboratory experiments to gauge immune escape and ACE2 binding affinity.
[Credits in the legend] * Only Spike RBD mutations considered
#SARSCoV2 lineages in the zone of concern (red box) - Predicted to have high immune escape and tight ACE2 binding activity - A Closer look
Chart: public.tableau.com/app/profile/ra…
What to expect in the next few weeks?
github.com/neherlab/SARS-…
Excellent SARSCoV2 Variant report
H/T
@richardneher @CorneliusRoemer
“Currently, XBB.1.16 is the big dog” ... “It’s picking up mutations that are common in other variants that will increase its advantage further.”
H/T @ErinMPrater @WellatFortune
@FortuneMagazine fortune.com/well/2023/03/3…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.